GE to Commercialize Cytori's Stem Cell Technology in North America

May 08, 2009

NEW YORK (GenomeWeb News) – GE Healthcare and San Diego-based Cytori jointly announced today that GE will commercialize Cytori's StemSource technology in North America for the stem cell banking and research markets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

Enzo Patent Found Invalid in Ongoing IP Lawsuits
Sciex Receives China FDA Approval for Mass Spec System
Hologic Receives CE Mark for Panther System Upgrade, Flu and Respiratory Assays
Rare Gut Condition Linked to Single Gene Mutations, Hyperactivation of Complement System
GenomeDx Prostate Cancer Tests Get New York State Approval
Genotyping, Fine Mapping Identifies Single-Variant Resolution Loci for IBD

The Scan

More Reproducible

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

To Catch the Swap

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

This Week in Cell

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.

Face of the Suspect

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

Main menu